Health and Wellness

NAMS calls for cancer to be declared notifiable disease, backs indigenous HPV test and vaccine rollout

Published by
Saurav Gupta

The National Academy of Medical Sciences (NAMS) has called for cancer to be classified as a notifiable disease and expects the upcoming inclusion of indigenous HPV tests and vaccines in the national health programme to significantly enhance cancer prevention and treatment.

During its 65th foundation day on Monday, NAMS highlighted key findings from its task force on cervical and breast cancer, stressing the need for robust data collection to inform health surveillance and policy decisions.

Officials underscored that women over 30 should undergo regular cancer screening, pointing to low current coverage rates.

Dr Neerja Bhatla, professor and former head of Obstetrics and Gynaecology at All India Institute of Medical Sciences (AIIMS), vice president of NAMS, and founding head of the WHO Collaborating Centre for Cervical Cancer Prevention at AIIMS, spoke about the state of cervical cancer testing in India.

Also read: A Delhi doctor’s self-exam protocol for early breast cancer detection

Dr Bhatla noted that although HPV testing is the main diagnostic method, its cost has spurred the development of more affordable local alternatives. These tests, suitable for primary care centres and requiring minimal training, are expected to be integrated into national efforts.

She added that these cost-effective, validated HPV tests—which target fewer genotypes—are now available and compatible with portable equipment, allowing for same-day screening and treatment.

Regarding vaccinations, Health Minister JP Nadda had informed the Lok Sabha last August that the National Technical Advisory Group on Immunisation had recommended introducing the HPV vaccine into the national immunisation schedule.

However, issues around dosage (single vs double) and implementation logistics remain. While external experts back a single-dose regimen, the government must ensure readiness for rollout.

Indigenous single-dose HPV vaccine trials are currently underway, with interim findings expected by 2026 and final data by 2027.

Also read: Closure of mohalla clinics sparks fear and anger in Delhi

Dr Bhatla also claimed that if an individual is vaccinated at the age of 15, then cervical cancer cases can be prevented by 80%.

Saurav Gupta

With nearly six years of experience as a journalist, he has written extensively on developmental issues, policies, health, and government agency schemes across both print and digital platforms. He holds a BAJMC degree from IP University.

Published by
Saurav Gupta
Tags: cancer

Recent Posts

Delhi: Absconder in 2021 rape case arrested after five-year chase

Police said despite sustained efforts, the accused remained at large and kept changing locations and…

January 11, 2026

A desert in motion: architect Mansi Trehan’s paintings at Bikaner House

At a debut solo exhibition in Delhi, an architect-artist explores sand, memory and movement through…

January 11, 2026

Not informing police biggest mistake: Elderly Delhi couple after losing Rs 14.85 Cr to cyber fraudsters

Om Taneja (81) and his wife Indira (77), a doctor, were kept under “digital arrest”…

January 11, 2026

Delhi court releases man convicted in fatal accident case on probation

The court observed although appellant had caused death by rash and negligent act, sending him…

January 11, 2026

Delhi Police detains AAP leaders protesting against BJP over Guru Tegh Bahadur issue

AAP leaders were detained during a protest against the BJP over an alleged doctored video…

January 11, 2026

NDMC to step up infrastructure, cleanliness efforts ahead of India AI Impact Summit in Delhi

NDMC is rolling out a G20-style upgrade of roads, lighting and cleanliness to prepare Delhi…

January 11, 2026